BLFS
Price
$24.46
Change
+$0.17 (+0.70%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
1.17B
56 days until earnings call
Intraday BUY SELL Signals
EMBC
Price
$12.60
Change
-$0.15 (-1.18%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
754.95M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLFS vs EMBC

Header iconBLFS vs EMBC Comparison
Open Charts BLFS vs EMBCBanner chart's image
BioLife Solutions
Price$24.46
Change+$0.17 (+0.70%)
Volume$1.68K
Capitalization1.17B
Embecta
Price$12.60
Change-$0.15 (-1.18%)
Volume$25.92K
Capitalization754.95M
BLFS vs EMBC Comparison Chart in %
BLFS
Daily Signal:
Gain/Loss:
EMBC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BLFS vs. EMBC commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and EMBC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (BLFS: $24.29 vs. EMBC: $12.75)
Brand notoriety: BLFS and EMBC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BLFS: 45% vs. EMBC: 49%
Market capitalization -- BLFS: $1.17B vs. EMBC: $754.95M
BLFS [@Pharmaceuticals: Other] is valued at $1.17B. EMBC’s [@Pharmaceuticals: Other] market capitalization is $754.95M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $193.82B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileEMBC’s FA Score has 2 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • EMBC’s FA Score: 2 green, 3 red.
According to our system of comparison, EMBC is a better buy in the long-term than BLFS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 2 TA indicator(s) are bullish while EMBC’s TA Score has 6 bullish TA indicator(s).

  • BLFS’s TA Score: 2 bullish, 6 bearish.
  • EMBC’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, EMBC is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а -4.41% price change this week, while EMBC (@Pharmaceuticals: Other) price change was +2.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.83%. For the same industry, the average monthly price growth was +0.69%, and the average quarterly price growth was -0.06%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 12, 2026.

EMBC is expected to report earnings on Feb 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-0.83% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($1.17B) has a higher market cap than EMBC($755M). EMBC YTD gains are higher at: 7.323 vs. BLFS (0.455). EMBC has higher annual earnings (EBITDA): 284M vs. BLFS (-14.25M). BLFS has less debt than EMBC: BLFS (20.7M) vs EMBC (1.43B). EMBC has higher revenues than BLFS: EMBC (1.08B) vs BLFS (100M).
BLFSEMBCBLFS / EMBC
Capitalization1.17B755M155%
EBITDA-14.25M284M-5%
Gain YTD0.4557.3236%
P/E RatioN/A7.87-
Revenue100M1.08B9%
Total Cash79MN/A-
Total Debt20.7M1.43B1%
FUNDAMENTALS RATINGS
BLFS: Fundamental Ratings
BLFS
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLFSEMBC
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 29 days ago
75%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signal:
Gain/Loss:
EMBC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NIEAX17.860.07
+0.39%
BNY Mellon International Equity A
PGEKX23.910.02
+0.08%
Victory Pioneer Global Equity R6
AILIX13.39-0.04
-0.30%
Cavanal Hill Hedged Equity Income Instl
OCLGX11.97-0.14
-1.16%
Optimum Large Cap Growth C
JNGTX70.14-1.21
-1.70%
Janus Henderson Glb Tech and Innovt D

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+1.63%
RGEN - BLFS
56%
Loosely correlated
-3.16%
RVTY - BLFS
51%
Loosely correlated
+1.25%
A - BLFS
50%
Loosely correlated
-0.27%
AZTA - BLFS
48%
Loosely correlated
+2.60%
DHR - BLFS
47%
Loosely correlated
+1.01%
More

EMBC and

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with AZTA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
+0.71%
AZTA - EMBC
41%
Loosely correlated
+2.60%
XRAY - EMBC
40%
Loosely correlated
+1.81%
WAT - EMBC
37%
Loosely correlated
-0.21%
MTD - EMBC
37%
Loosely correlated
+0.05%
BLFS - EMBC
36%
Loosely correlated
+1.63%
More